POPULARITY
16 episodes with early diagnosis
10 episodes with early diagnosis
6 episodes with early diagnosis
16 episodes with early diagnosis
10 episodes with early diagnosis
10 episodes with early diagnosis
8 episodes with early diagnosis
10 episodes with early diagnosis
8 episodes with early diagnosis
13 episodes with early diagnosis
6 episodes with early diagnosis
7 episodes with early diagnosis
3 episodes with early diagnosis
6 episodes with early diagnosis
4 episodes with early diagnosis
2 episodes with early diagnosis
3 episodes with early diagnosis
2 episodes with early diagnosis
We dive deep into the real world impact of leg length discrepancy (LLD) with two athletes - one who corrected it, and one who's considering the journey.⚽ Sam, a former semi-pro soccer player, shares how a 2.3cm congenital tibial discrepancy affected his mobility and performance. After undergoing tibial lengthening surgery, he's now able to run, perform agility, do marathons and play with his son without pain and plans to compete in a soccer tournament this fall - he shares everything about the recovery, rehab, and mental shift that came with it.
A Gluten Free Podcast Episode 184 In this episode of A Gluten Free Podcast, I'm joined by Dr. Andrew Williams, Principal Scientist at Westmead Children's Hospital in Sydney, Australia. Dr. Williams has spent decades researching coeliac disease and the complex immunological processes behind it. We explore how coeliac disease research has evolved, what still needs to change, and how early diagnosis in children could significantly improve health outcomes across Australia and globally.We dive into the inspiration behind Dr. Williams' career in immunological research, his earliest experiences working with children diagnosed with coeliac disease, and what initially drew his attention to this autoimmune condition. With so many people still undiagnosed, we talk about how Australia compares to other countries like Italy, where screening children for coeliac disease and Type 1 diabetes is already underway.We also discuss promising innovations like the Novoleukin blood test—a tool being developed to detect coeliac disease even in people who are already on a gluten-free diet. This episode offers a hopeful and practical look into how coeliac disease awareness, testing methods, and healthcare systems could shift for the better—if we focus our efforts in the right places.What We Cover:How Dr. Andrew Williams became involved in coeliac disease researchWhat we knew (and didn't know) about coeliac disease when he began his careerMajor milestones in coeliac disease research over the past few decadesReal-life stories from the clinic that shaped his perspectiveThe critical need for early diagnosis in children with coeliac diseaseWhy so many Australians remain undiagnosed and what needs to changeHow other countries like Italy are taking proactive steps to improve coeliac screeningThe future of coeliac disease testing, including the upcoming Novoleukin diagnostic toolWhat parents of children with coeliac disease need to knowHow one powerful conversation reminded him why this work matters
On the "Sound of Ideas" we will talk to several people living with ADHD, and a doctor who works in diagnosis and treatment.
Today, we're speaking to Professor Martijn Schut, Professor of Translational AI in Laboratory Medicine and Professor Henk CPM van Weert, GP and Emeritus Professor of General Practice, both based at Amsterdam University Medical Center.Title of paper: Artificial intelligence for early detection of lung cancer in GPs' clinical notes: a retrospective observational cohort studyAvailable at: https://doi.org/10.3399/BJGP.2023.0489In most cancers, the prognosis depends substantially on the stage at the start of therapy. Therefore, many methods have been developed to enhance earlier diagnosis, for example, logistic regression models, biomarkers, and electronic-nose technology (exhaled volatile organic compounds). However, as most patients are referred by their GP, who keeps life-long histories of enlisted patients, general practice files might contain hidden information that could be used for earlier case finding. An algorithm was developed to identify patients with lung cancer 4 months earlier, just by analysing their files. Contrary to other methods, all medical information available in general practice was used.TranscriptThis transcript was generated using AI and has not been reviewed for accuracy. Please be aware it may contain errors or omissions.Speaker A00:00:01.600 - 00:00:55.370Hello and welcome to BJGP Interviews. I'm Nada Khan and I'm one of the associate editors of the journal. Thanks for taking the time today to listen to this podcast.Today we're speaking to Professor Martin Schutt, who is a professor in translational AI and Laboratory medicine, and Professor Hank Vanwort, GP and Emeritus professor in General Practice, who are both based at Amsterdam University Medical Center. We're here to discuss their paper, which is titled Artificial Intelligence for Early Detection of lung cancer in GP's clinical notes.So, yeah, it's great to see you both here today. And Martin, I'll come to you first.I suppose we know that it's important to try and diagnose cancer early, but could you talk us through what's the potential for artificial intelligence here in terms of identifying cancer earlier based on patient records?Speaker B00:00:55.810 - 00:01:52.220Yeah, that's a very interesting question because the potential kind of like goes hand in hand with the huge amount of interest in AI. And I think there are great opportunities. There are also great challenges.But talking about the opportunities, especially in the context of the article that we wrote, is on the data side. So on the data side, the digitalization of electronic health records gives great opportunities.A lot more is digitalized, and that means that we also, in our case, have access to free text, and that we, with the advent of the large language models, with also new developments in AI, we also have better ways of making use of those data. So those two combined creates a really interesting formula for big opportunities for AI in the general practice and healthcare in general.Speaker A00:01:52.300 - 00:02:05.960And you mentioned access to free text records. So what GPs are typing into the record records?But before we get into the study, can you just briefly describe what is natural language processing and how that can be used in free text records?Speaker B00:02:06.760 - 00:03:10.100So we know that a lot of clinical risk scores, they work with features of patients, so their age and their gender or sex. And. But of course, a lot of information is also written up in unstructured way. And in our case that is...
A short but uplifting episode, with a timely update on an important medical research project that seeks to isolate and establish what is hoped will prove to be unique bio-markers for Parkinson's disease. Our interiewee is Claire Guest OBE, whose charity, Medical Detection Dogs has been at the forefront of some remarkable breakthroughs using bio detection dogs. When Dogs with Jobs visited in 2023, the charity was just starting to consider whether its work could extend into Parkinsons - which is hard to diagnose currently. The classic sympoms of Parkinsons, such as tremors, become obvious only late on. So any contribution towards earlier diagnosis could bring a huge benefit to patients and allow earlier intervention. Kate Fairweather grabs an update, before Claire disappears to the Literary Corner to read aloud from her book at Goodwoof 2025. Recorded at Goodwoof 2025. Connected episodes lorin, Iggy and Asher, bio detection dogs and owner, Dr. Claire Guest OBE Hear E-Coli detection dog Plum at work at the charity's training centre. Medical Alert dogs Do you work your dog or know someone else who might like to come on the show? Get in touch with Kate, via team@shineradio.uk. Find more dogs with interesting jobs. © & ℗ Kate Fairweather, 2025See omnystudio.com/listener for privacy information.
A short but uplifting episode, with a timely update on an important medical research project that seeks to isolate and establish what is hoped will prove to be unique bio-markers for Parkinson's disease. Our interiewee is Claire Guest OBE, whose charity, Medical Detection Dogs has been at the forefront of some remarkable breakthroughs using bio detection dogs. When Dogs with Jobs visited in 2023, the charity was just starting to consider whether its work could extend into Parkinsons - which is hard to diagnose currently. The classic sympoms of Parkinsons, such as tremors, become obvious only late on. So any contribution towards earlier diagnosis could bring a huge benefit to patients and allow earlier intervention. Kate Fairweather grabs an update, before Claire disappears to the Literary Corner to read aloud from her book at Goodwoof 2025. Recorded at Goodwoof 2025. Connected episodes lorin, Iggy and Asher, bio detection dogs and owner, Dr. Claire Guest OBE Hear E-Coli detection dog Plum at work at the charity's training centre. Medical Alert dogs Do you work your dog or know someone else who might like to come on the show? Get in touch with Kate, via team@shineradio.uk. Find more dogs with interesting jobs. © & ℗ Kate Fairweather, 2025See omnystudio.com/listener for privacy information.
In this powerful and deeply personal episode, Parul Dua Makkar, BSc, DDS, FACD, shares how the loss of her younger brother, Manu Dua, DDS, to oral cancer changed the course of her life and career. Manu was a healthy, young dentist with few risk factors, yet his diagnosis came late — a reality that highlights the critical need for early detection and awareness. Dr. Makkar opens up about her brother's story, the warning signs that were missed, and the emotional toll of watching a loved one navigate cancer. She also offers practical advice for healthcare providers on how to talk to patients about suspicious lesions, the importance of regular screenings, and the shifting demographics of oral cancer. Following Manu's death, she authored the book Life Interrupted: Dr. Dua's Survival Guide. A passionate advocate, speaker, and award-winning author, Dr. Makkar is on a mission to educate both clinicians and the public about the importance of recognizing oral cancer risks—before it's too late. She is a Board member American Academy of Oral Systemic Health and a Fellow for the American College of Dentists.
Imagine being able to detect Alzheimer's disease 10-30 years before the first symptoms appear—when interventions could potentially prevent cognitive decline entirely.In this second episode of our four-part series on Alzheimer's prevention, I explore the revolutionary blood biomarker tests that are changing our approach to brain health. Learn how these simple blood tests can detect Alzheimer's-related changes with 90% accuracy, why they're not yet widely available despite their promise, and what this means for your prevention strategy.What to Listen For[01:00] The three phases of Alzheimer's disease and why early detection is critical.[02:30] How amyloid plaque accumulation starts 10-30 years before symptoms appear.[04:15] The role of tau tangles and neuroinflammation in Alzheimer's progression.[07:00] The cancer staging analogy: why we're currently waiting until the equivalent of "stage 3" to diagnose Alzheimer's [08:30] How new blood biomarker tests detect Alzheimer's in its “stage 0 or 1.”[10:45] The surprising role of amyloid beta—why it's not all bad.[12:00] The critical tipping point in amyloid accumulation—why timing matters.[14:15] Alternative pathways to Alzheimer's: traumatic brain injuries, infections, vascular issues and metabolic dysfunction.[18:30] The connection between sleep and amyloid clearance—why quality sleep is essential for brain health.[21:00] Why blood biomarker tests are a game changer compared to PET scans and spinal taps.[24:00] Four key biomarkers these tests measure: amyloid beta, tau proteins, neurofilament light chain, and inflammatory markers [28:00] Why these tests cost $1,500 and aren't covered by insurance despite their potential [31:00] Three practical steps you can take now if you're concerned about your risk While our healthcare system is still catching up to the revolutionary potential of blood biomarker tests for Alzheimer's detection, these tests represent an unprecedented opportunity to identify the disease in its earliest stages.Even with current limitations in accessibility, knowing your risk factors empowers you to take preventive action decades before symptoms might appear. Stay tuned for our next episode, where we'll explore pharmaceutical interventions that could change the course of Alzheimer's treatment.If you found this episode valuable, be sure to subscribe, share it with a friend, and check out last week's episode on early prediction and genetics to build a full understanding of Alzheimer's prevention.RESOURCES: Book a FREE Discovery Call with Amy Lang Order Amy's book Thoughts Are Habits Too: Master Your Triggers, Free Yourself From Diet Culture, and Rediscover Joyful Eating. Follow Amy on Instagram @habitwhisperer
It's estimated 65,000 New Zealand are already living with the eye disease glaucoma, but are totally unaware.
In today's episode, we dive into the wonders of T-cell immunology technology and how it impacts early treatment interventions with long-time drug developer Dr. Nigel McCracken. As the Chief Operating Officer of Virax Biolabs, Dr. McCracken has more than 25 years of research and development experience in this diverse field – including oncology and infectious disease… Virax Biolabs is committed to revolutionizing global health by accelerating the development of more effective vaccines. How do they achieve this? By harnessing cutting-edge diagnostics to power a groundbreaking T-cell immunology platform, enabling early detection of post-viral syndromes and conditions linked to chronic inflammation and T-cell exhaustion. Before joining Virax, Dr. McCracken served as Chief Scientific Officer at BerGenBio ASA, where he led the development of companion diagnostics and assay strategies. Prior to that, he was COO at NuCana PLC, a clinical-stage biopharmaceutical company dedicated to improving cancer treatment outcomes. In this role, he oversaw business operations, research and development, and the execution of corporate strategy. Tune in now to learn about: The importance of early diagnosis when it comes to immune system dysfunction. How the complementary system interacts with the immune system. The typical role that T-cells play in infections. Why chronic health problems are on the rise, and what this could mean for the future of healthcare. You can follow along with Dr. McCracken's work at Virax Biolabs here! Episode also available on Apple Podcasts: https://apple.co/30PvU9C Upgrade Your Wallet Game with Ekster! Get the sleek, smart wallet you deserve—and save while you're at it! Use coupon code FINDINGGENIUS at checkout or shop now with this exclusive link: ekster.com?sca_ref=4822922.DtoeXHFUmQ5 Smarter, slimmer, better. Don't miss out!
Elder Care Coordinator Pati Bedwell speaks with Dr. Veronique Belzil, an Associate Professor of Neurology at Vanderbilt University Medical Center. Dr. Belzil also serves at the Director of the Vanderbilt ALS Research Center.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA credit will be available until January 19, 2026.The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sage Therapeutics and Biogen.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA credit will be available until January 19, 2026.The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sage Therapeutics and Biogen.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA credit will be available until January 19, 2026.The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sage Therapeutics and Biogen.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA credit will be available until January 19, 2026.The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sage Therapeutics and Biogen.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA credit will be available until January 19, 2026.The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sage Therapeutics and Biogen.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA credit will be available until January 19, 2026.The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sage Therapeutics and Biogen.Disclosure information is available at the beginning of the video presentation.
When dealing with a parent's concern about their child's communication, a pediatric audiologist may face multidisciplinary issues and need to make referrals. This episode's guests say pediatric audiologists may be the first step in a larger health care journey. They highlight the importance of delivering appropriate services to families at a critical time. Hear from two pediatric audiologists who work as instructors at LEND (Leadership Education in Neurodevelopmental and Related Disabilities) programs. We're dedicating this episode to these multidisciplinary training programs, and their role in preparing pediatric audiologists.Plus, one LEND instructor in North Carolina shares a personal connection to her work.Learn More:Developing Future Pediatric Audiology Leaders: The LEND ExperienceGeorgia Puts Pediatric Hearing Care on Wheels to Address Service ShortagesPediatric Audiologists: Partners in Early Diagnosis of Autism
Are you focusing enough on pink aesthetics in smile design? What role does gingiva play in achieving a truly stunning smile? When should you refer for recession around lower incisors or upper canines? Can you get the gum to grow back through orthodontics? And how about class 5 restorations? Should we do them, or should we work on the gingival recession first? In this episode, Jaz is joined by the expert Dr. Tidu Mankoo, who shares his extensive knowledge on the importance of gingival health in aesthetic dentistry. They dive into the crucial role of the dento-gingival complex. https://youtu.be/Ao_vgJ-IbOg Watch PDP208 on YouTube Protrusive Dental Pearl: Shade Matching Composite button technique - a small blob of composite is applied to a dry tooth without etching or bonding to assess shade match and translucency, avoid excess thickness, which can affect opacity and aesthetics (Jason Smithson's Tip: take a black-and-white photo to evaluate the composite's value and ensure it matches the natural teeth) Using a custom composite shade guide like Smile Line by Style Italiano for more precise shade matching. Key Takeaways Gingival architecture plays a vital role in aesthetics. Dentists should focus on patient-centered care. Understanding tooth position is key to treatment planning. Orthodontics can sometimes resolve gingival issues without surgery. Communication with patients is essential for effective treatment. Aesthetic dentistry requires a comprehensive approach. The dental field is evolving, and practitioners must adapt. Root coverage procedures can be effective with proper techniques. Understanding prognosis is crucial for successful treatment outcomes. Aesthetic considerations are a primary reason for root coverage. Restorative dentistry should consider the position of the gingiva. Crown lengthening should not expose root surfaces unnecessarily. Mucogingival surgery plays a vital role in implant aesthetics. Education and training are essential for dental professionals. Highlights for this episode: 4:29 Protrusive Dental Pearl 6:16 Dr. Tidu Mankoo's Journey and Inspirations 11:48 Reflections on Comprehensive Dentistryand Lifelong Learning 15:59 Balancing Work and Family in Dentistry 17:52 Understanding Gingival Architecture 19:49 Creating a Harmonious Smile 21:52 Addressing Gingival Aesthetics & Limitations 26:56 Orthodontics and Surgical Interventions 29:40 Root Coverage Procedures 33:49 The Value of Early Diagnosis and Referral 35:01 Indications for Root Coverage 36:03 Root Coverage vs. Class V Restorations 39:50 Managing Gingival Zenith Irregularities 41:23 Role of Mucogingival Surgery inImplant Success 47:47 Course on Mucogingival Surgery with IAS This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance. This episode meets GDC Outcomes B and C. AGD Subject Code: 780 ESTHETICS/COSMETIC DENTISTRY (Esthetic diagnosis and treatment of intraoral soft tissues) Dentists will be able to - Discuss when and how to manage gingival recession, including the role of root coverage procedures. Explore the anatomy and function of the dento-gingival complex and its influence on smile aesthetics. Promote the value of early diagnosis and timely referrals to specialists for successful treatment.
In this episode we discuss the recent National Society of Genetic Counselor's Practice Resource on Dystrophinopathies, which was recently published in JoGC, with two of the publications' authors. You can find the Journal of Genetic Counseling webpage via onlinelibrary.wiley.com or via the National Society of Genetic Counselors website. Segment 1: “Genetic counseling for the dystrophinopathies- Practice resource of the National Society of Genetic Counselors” Ann Martin, MS, CGC is a board certified genetic counselor with Parent Project Muscular Dystrophy (PPMD). Ann serves as the VP of Community Research and Genetic Services and manages a team of genetic counselors who coordinate all aspects of The Duchenne Registry and the Decode Duchenne genetic testing program. Since joining PPMD in 2011, Ann has been directly involved in all aspects of the Registry programs including collection and curation of the Registry data, clinical trial and research study recruitment, data exports, patient and family inquiries, genetic testing, and educational content on the PPMD websites. Ann represents The Duchenne Registry on TREAT-NMD's Global Data Oversight Committee, which is responsible for reviewing requests for data from the TREAT-NMD Global Registries, and serves as the DMD Subgroup Co-Lead. In addition, Ann has been a member of Sarepta Therapeutics' Advisory Board for Early Diagnosis of Duchenne since 2022. Ann is continually engaging and educating both the patient and professional community about the Registry and Duchenne and Becker research. Before joining PPMD, Ann worked as a clinical genetic counselor for 15 years at Carolinas Medical Center in Charlotte, NC, where she provided genetic counseling for pediatric and adult patients with a wide range of genetic disorders. Ann is a graduate of the University of Cincinnati Genetic Counseling Graduate Program. She is board-certified by the American Board of Genetic Counseling and is a member of the National Society of Genetic Counselors. Angela Pickart (she/her) is a licensed, certified genetic counselor practicing in the Genomics Laboratory at Mayo Clinic, performing variant interpretation, report writing and test development for neurogenetics assays. She received her Master of Science degree in Genetic Counseling at the University of Minnesota and has extensive clinical experience in pediatric, neurology, and oncology genetic counseling prior to transitioning to her laboratory role. She has been awarded the academic rank of Assistant Professor of Laboratory Medicine at the Mayo Clinic College of Medicine and Science where she serves as course co-director of the Center for Clinical and Translational Sciences Molecular Variant Evaluation Course. She is also the course co-director of the Laboratory Practicum for the Medical College of Wisconsin Master of Science Genetic Counseling Graduate Program and Adjunct Assistant Professor of the Medical College of Wisconsin School of Graduate Studies. In this segment we discuss: - Origins and significance of the genetic counseling-specific practice resource for dystrophinopathies. - Changes in the treatment landscape due to FDA-approved therapeutics and ongoing clinical trials for dystrophinopathies. - Strategies for educating patients and families about the implications of genetic testing and diagnosis in dystrophinopathies. - Advocacy roles of genetic counselors in helping patients access the latest therapies and participate in clinical trials for DMD/BMD. - Importance of interdisciplinary collaboration in managing dystrophinopathies and the roles genetic counselors play within these teams. - Potential broader impact of the practice resource on the medical field and patient community. Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors. Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”. For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others. Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com. DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Sydney Arlen.
CME credits: 0.50 Valid until: 13-12-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-shifting-attr-cm-landscape-early-diagnosis-emerging-therapies-personalized-care/27090/ Achieving optimal outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) remains a challenge as diagnosis is often delayed. Patients have a reduced life expectancy and experience debilitating pain and poor quality of life. Hear from the experts as they review the latest information on new and emerging treatment options for transthyretin amyloidosis and how this condition affects patients with cardiomyopathy.=
Please visit answersincme.com/ZPD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatologic diseases discusses the diagnosis and treatment of bullous pemphigoid. Upon completion of this activity, participants should be better able to: Review the clinical impact of bullous pemphigoid (BP) on patients; Outline diagnostic approaches to enhance the timely identification of patients with BP; and Identify clinical advances that may evolve the therapeutic paradigm for patients with BP.
Please visit answersincme.com/ZPD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatologic diseases discusses the diagnosis and treatment of bullous pemphigoid. Upon completion of this activity, participants should be better able to: Review the clinical impact of bullous pemphigoid (BP) on patients; Outline diagnostic approaches to enhance the timely identification of patients with BP; and Identify clinical advances that may evolve the therapeutic paradigm for patients with BP.
Dr. Refky Nicola talks with Dr. Wendy VanBuren and Dr. Priyanka Jha about advances in endometriosis imaging, focusing on ultrasound, MRI, and the role of T1 and T2 sequences in diagnosis and reporting. Radiology State-of-the-art Review:Endometriosis Imaging Interpretation and Reporting. VanBuren et al. Radiology 2024; 312(3):e233482.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PUG865. CME/MOC/AAPA/IPCE credit will be available until November 20, 2025.Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PUG865. CME/MOC/AAPA/IPCE credit will be available until November 20, 2025.Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
Van writes in with, 'A friend is encouraging me to take a cancer screening test that screens for many different cancers. A review of one test says: "While overall it picks up 90% of stage 4 cancers, it only detects an average of 17% of stage 1 cancers. Yet it is being touted as a test that can detect cancer early." Are these tests worthwhile?' James Tytko took on the question with the help of Professor Rebecca Fitzgerald, Founding Director of the Early Detection Institute at the University of Cambridge... Like this podcast? Please help us by supporting the Naked Scientists
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
Chronic Lyme disease, characterized by persistent symptoms that can linger for months or even years, is a growing concern for both patients and healthcare providers. Traditionally, Lyme disease has been seen as a straightforward infection—diagnosed early, treated with antibiotics, and resolved. However, for a significant number of people, Lyme disease can evolve into a chronic condition, marked by ongoing fatigue, pain, and cognitive issues. But what if much of this chronic suffering could be prevented? Recent insights suggest that the progression to chronic Lyme disease might be mitigated, or even prevented, by focusing on several key factors. This approach is similar to how we prevent other chronic diseases like type 2 diabetes or heart disease: through early detection and appropriate treatment. **The Importance of Early Diagnosis and Treatment** One of the most critical steps in preventing chronic Lyme disease is the early diagnosis and treatment of the infection. When a patient presents with a tick bite or early symptoms of Lyme disease, such as the characteristic erythema migrans rash, it's vital to begin treatment promptly. Early intervention with antibiotics like doxycycline can significantly reduce the risk of the infection progressing to a chronic stage. Moreover, it's essential to maintain a vigilant follow-up process. Even after initial treatment, patients should be asked to return for evaluation if symptoms persist or recur. Lyme disease can sometimes be insidious, with symptoms reappearing after what seems like successful treatment. Regular follow-ups allow healthcare providers to monitor the patient's progress and catch any signs of relapse early. **Look for Co-Infections** Co-infections are another critical factor in the progression of Lyme disease to a chronic condition. Ticks often carry more than just Borrelia burgdorferi, the bacteria responsible for Lyme disease—they can also transmit other pathogens like Babesia, Bartonella, and Anaplasma. These co-infections can complicate the clinical picture and may require different treatments. It's important to test for and consider co-infections, especially if a patient's symptoms do not resolve with standard Lyme treatment. Addressing all possible infections early on can prevent the persistence and worsening of symptoms. **Consider Retreatment** In cases where initial treatment does not fully resolve the symptoms, it may be necessary to consider retreatment. Clinical judgment plays a crucial role here. While some cases of Lyme disease respond well to the standard course of antibiotics, others may require a more prolonged or alternative treatment approach. Retreatment should be considered for patients who continue to experience significant symptoms, particularly if they show signs of ongoing infection or co-infections. **Follow-Up Care is Crucial** Consistent follow-up care is essential in managing Lyme disease and preventing its progression to a chronic state. Even after symptoms appear to have resolved, patients should be monitored for any signs of recurrence or new symptoms. Chronic Lyme disease can sometimes develop months or even years after the initial infection, making long-term follow-up a key component of care. **Environmental Awareness and Preventive Measures** **Raising Awareness and Improving Access to Care**
In this episode of AiArthritis Voices 360, co-hosts Leila and Eileen discuss a project focused on organizing essential resources for patients navigating the AiArthritis journey, from undiagnosed symptoms to remission. They share their personal experiences living with lupus and rheumatoid arthritis, exploring the complexities of managing chronic illness and the challenges of early diagnosis. Tune in to learn about AiArthritis's new online social community and how you can contribute your story and help develop more resources for patients. This episode is perfect for patients and caregivers seeking guidance and support on their health journey. Share your ideas on resources that we can add to the patient journey by emailing us at info@aiarthritis.org, submit your patient story on each different section of the patient journey and join our online social community! Episode Highlights A breakdown of the six stages of the patient journey and how resources are organized. Personal stories from Leila and Eileen on living with AiArthritis diseases. The importance of early diagnosis and how it affects long-term outcomes. Strategies for caregiver support and understanding comorbidities. Learn how to contribute your story or join the new AiArthritis social community. Resources & Links: Check out our patient resources: www.aiarthritis.org/patientjourney Volunteer with AiArthritis : https://bit.ly/AiArthritisVolunteerApp Donate to Support the Show: https://www.aiarthritis.org/donate Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE Connect with our Co-Hosts: Leila is the Health Education Manager at the International Foundation for AiArthritis. She is a person living with Lupus and Sjögren's disease. She is passionate about inclusion and diversity in health education and meeting individuals where they are at in order to learn in a way that resonates with them. Connect with Leila: Tiktok: @Lupuslifestyle.lei Eileen is a rheumatoid arthritis patient advocate from Vancouver Canada. She volunteers with the Arthritis Research Canada patient advisory board and the Canadian Institute of Health Research - Institute of Musculoskeletal Health and Arthritis patient engagement research ambassador, among others. When not advocating she is writing about her experience with arthritis through Creaky Joints, Healthline, Chronic Eileen or can be found being a mom to her son Jacob. Connect with Eileen: ChronicEileen
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. CME/MOC/NCPD/AAPA credit will be available until September 29, 2025.Keeping PACE™ in Alzheimer's Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. CME/MOC/NCPD/AAPA credit will be available until September 29, 2025.Keeping PACE™ in Alzheimer's Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. CME/MOC/NCPD/AAPA credit will be available until September 29, 2025.Keeping PACE™ in Alzheimer's Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
Madison Cotton went to her Primary Care Physician because of troubling cysts in her breast in 2017 and the fact that her mother had already been through breast cancer. Madison was basically dismissed by her doctor and eventually in 2022 was diagnosed with Breast cancer. Since that time she has struggled both physically and emotionally with a variety of difficult issues that she has gone through as an AYA cancer patient, and has only begun to feel better and have a more meaningful existence during this summer season.
What if we could accurately predict diseases years before symptoms appear without invasive procedures? How would that transform the troubled landscape of modern healthcare? That's the topic of conversation this week when I chat with Dr. Jonathan Hill, Associate Professor of Cell Biology at BYU and VP of Science and Technology at Wasatch. Together, we're exploring the cutting-edge intersection of AI and DNA sequencing. We unpack AI's hidden potential to decode the complex patterns hidden within our DNA, paving the way for early diagnosis and better treatment options. In our conversation, Dr. Hill shares how his pivot from traditional medicine led to his current work at the forefront of biological research. You'll learn more about his team's innovative work in DNA methylation and how AI-driven diagnostics could radically change the landscape of modern medicine. In parallel, we talk through some of the challenges of innovation, like the chasm between academic research and practical execution, the importance of change management, and how, despite its tremendous potential, AI isn't for everything. Whether you're a tech enthusiast, a healthcare professional, or simply curious about the future of medicine, you'll walk away from this one both inspired and informed. So, come check out how the secrets encoded in our DNA are being unlocked, one AI-driven discovery at a time. Show Notes: In this episode, Christopher talks with Dr. Jonathan Hill, an Associate Professor of Cell Biology at BYU and VP of Science and Tech at Wasatch, to explore the intersection of AI and DNA sequencing. The discussion highlights how AI is being leveraged for early diagnostic techniques, particularly in neurodegenerative diseases like Alzheimer's. Dr. Hill also shares insights into the collaborative approaches taken to bridge the gap between academic research and practical application. The conversation tackles the essentials of integrating AI models, ensuring the cleanliness of data, and the future of healthcare diagnostics powered by advanced technology. Don't miss this insightful dialogue that unpacks the challenges and breakthroughs in healthcare innovation. 00:00 - Introduction 01:14 - Guest Introduction: Dr. Jonathan Hill 06:56 - Challenges in Translating Research to Practice 13:33 - Collaboration and Innovation in DNA Sequencing 26:20 - Early Diagnosis of Alzheimer's with DNA Sequencing 32:10 - Innovative Lab Approaches 34:05 - Challenges and Benefits of Healthcare Innovation 40:46 - AI in Diagnostics: Three Levels of Application 51:22 - Simplifying Diagnostic Processes 01:03:44 - The Future of AI in Healthcare #ai #healthcare #diagnostics #artificialintelligence #Alzheimers
"We are the experts on our daughter and we deserve a say, and we deserve to be given the time to ask questions." – Nikki DeLeo We extend our sincere gratitude to our sponsor for this episode, Gebauer PainEase®. We are pleased to provide more information about this product, and we invite you to learn more by visiting their website. In this heartfelt episode, host and Certified Child Life Specialist Katie Taylor speaks with Nikki DeLeo, a mother of Taylor, her daughter who has Cystic Fibrosis (CF). Katie and Nikki discuss Nikki's journey navigating her daughter Taylor's diagnosis from day one, the emotional rollercoaster of becoming a medical parent, her advocacy for Taylor's care, and the importance of equity in newborn screenings for CF. With Taylor's unique case, Nikki discusses the challenges and triumphs of managing a life-changing diagnosis, emphasizing the role of medical teams and community support in fostering resilience and hope. Key Insights: The Importance of Early Diagnosis: Nikki emphasizes how critical early diagnosis was for her daughter Taylor, who started life-saving medication within months of her birth. Advocacy and Education: Nikki shares how she became an expert in her daughter's care, highlighting the necessity of parents being active members of the care team. Equity in Healthcare: Nikki passionately discusses the disparities in newborn screenings for children of color and the need for equity in medical care to prevent delayed diagnoses. The Power of Community: Finding other parents online and connecting with the Cystic Fibrosis Foundation were vital for Nikki in navigating the challenges of CF. "Finding other parents online who are going through the same thing has been a lifeline for me." – Nikki DeLeo Resources & Tips: Cystic Fibrosis Foundation: Visit the CF Foundation to find local chapters and resources for parents and caregivers. Book Recommendation: Breath from Salt - An insightful book about the CF community and the advancements in CF care. Follow Nikki's Journey: Check out Nikki's Instagram page, @salt_for_sweet_t, for more on her family's journey. When parents feel empowered, everyone wins – kids thrive and the care team excels! Links and Resources: SupportSpot Website Download SupportSpot iOS or Android 85% of users report high satisfaction, appreciating the Child Life On Call App's comprehensive resources and user-friendly interface. 92% of parent users say the Child Life On Call App helped them understand medical procedures and treatment better. 80% of parents believe the Child Life On Call App has contributed to better health outcomes for their child. 73% of parent users believe the Child Life On Call App has made them feel more empowered to advocate for their child in healthcare Learn more here. Meet the host: Katie Taylor is the co-founder and CEO of Child Life On Call, a digital platform designed to provide parents, kids, and the care team with access to child life services tools and resources. She is a certified child life specialist with over 13 years of experience working in various pediatric healthcare settings. Katie is the author of the children's book, and has presented on the topics of child life and entrepreneurship, psychosocial care in the hospital, and supporting caregivers in the NICU setting both nationally and internationally. She is also the host of the Child Life On Call Podcast which features interviews with parents discussing their experiences throughout their child's medical journey. The podcast emphasizes the crucial role of child life services in enabling caregivers both at and beyond the bedside. Instagram.com/childlifeoncall Facebook.com/childlifeoncall linkedin.com/in/kfdonovan
Identifying signs of ADHD in preschool-aged children can be a challenge. Learn how to differentiate between typical development and behaviors that may indicate ADHD during the early childhood years from Alexis Bancroft, Ph.D., and Cynthia Martin, Psy.D. ADHD in Preschool: More Resources Self-Test: ADHD Symptoms in Children Read: Isn't My 4-Year-Old Too Young to Be Diagnosed With ADHD? Read: “The Day My Hyperactive Toddler Aced His ADHD Test” eBook: A Parent's Guide to Effective Routines Access the video and slides for podcast episode #516 here: https://www.additudemag.com/webinar/signs-of-adhd-preschool-symptoms/ Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.
Our guest today is an expert on how to enhance your human biology. Dr. Darshan Shah is a board-certified surgeon and entrepreneur. He's the Founder of Next Health, the first and largest clinics for human health optimization and longevity.Right now, you could be adding an extra 15% to your mortality rate and not even know it. But by understanding what to eliminate and where to focus your efforts, you can set yourself on the path towards optimal health and wellness. If you're looking for the extra edge, both physically and mentally, this episode is for you.Chapters:Timestamp Summary | 0:00 | Preventing Metabolic Disease to Avoid Major Health Issues | 8:27 | Maui Nui Venison Sticks: The Ultimate High-Protein Snack | 10:23 | Understanding Autoimmune Diseases and Their Root Causes | 16:51 | Key Biomarkers and Monitoring for Metabolic Syndrome | 25:10 | Understanding Cardiovascular Disease and the Importance of Lipid Panels | 33:59 | Navigating Statins, Lifestyle Changes, and Personalized Health Interventions | 40:21 | The Benefits of Infrared Saunas and Self-Care Routines | 43:29 | Preventing Alzheimer's Through Lifestyle Changes and Early Diagnosis | 47:53 | Detoxifying Your Life and Improving Gut Health | 54:52 | Advanced Longevity Therapies and Plasma Exchange at Next HealthSponsorsMomentous - Use code NEURO to get 20% off your order - https://www.livemomentous.com/neuroMaui Nui Venison - Use code NEURO to get 20% off your first order of fresh venison, jerky, broth, and ‘ohana subscription while supplies last. https://mauinuivenison.com/pages/NEURODarshan Shah:https://www.instagram.com/darshanshahmdhttps://www.drshah.com/The Neuro Athletics Newsletter Instagram: @louisanicola_Twitter : @louisanicola_YouTube: @Louisa NicolaThe Neuro Experience Podcast is proud to have hosted: Dr Andrew Huberman, Dr Gabrielle Lyon, Dr Layne Norton, Thomas DeLauer, Shawn Stevenson, Dr. Rocio Salas-Whalen, Saad Alam, Uma Naidoo, Dr. Lanna Cheuck, Angela Lee Pucci, Jillian Turecki, Dr. Jordan Feigenbaum, Dr. Darren Candow, Dr. Sue Varma, Evy Poumpouras, Dr Casey Means, Renee Deehan, Dr Chris Palmer, Dr Charles Brenner, Dr Joe Zundell
In this episode, we explore typical topics with Autism research and try to understand the purpose. Autism research is confounding, and maybe, lacks direction. We offer a research suggestion based on the most plausible cause of Autism- the new modern day environmental factor- Artificial Light. Remember, Autism just shows up, so it makes sense to send the mother and father back to an environment pre-Autism.Quantum Biology https://www.patreon.com/DrJackKruse/postsPhotobiological Implications of Folate https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862485/B9 (folate) and B12 (cobalamin) are Photoreceptors, too.0:00 Autism Research Direction and missing the beginning; Is it Click-Bait?; Confounding3:30 Changes in Light and the Full Spectrum; the number of Genes involved with Autism Research5:07 Genetic Variants, Copy Number, Duplications, Deletions7:04 Gene-Envrionment Interaction; MTHFR; Methylation, Myelin13:03 Brain Connectivity and Neurobiology13:55 Socio-Environmental/Socioeconomic; Robert Sapolsky14:25 Early Diagnosis and Bio-markers14:47 Comorbid Conditions16:05 Personalized Interventions16:27 Medications and the PROFIT MILL18:36 Today's Purpose; Parental Melanin, Artificial Light, and nnEMF19:30 Research Idea with 3 Groups and Returning the Environment before Autism magically shows up25:17 Shift-Work Warning26:20 Back to Autism; Amish29:07 Reviews/Ratings, Contact InfoX: https://twitter.com/rps47586Hopp: hopp.bio/fromthespectrumemail: info.fromthespectrum@gmail.com
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter? Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria. OP0046 Effect on SI joint structural lesions with ixekizumab POS0058 Effect on SI joint structural lesions with bimekizumab Does Telemonitoring in SpA Work? Dr. Antoni Chan reports on abstract OP0120 from Eular 2024 in Vienna, Austria. Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria. Treat to Target Outcomes in Early AxSpA Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria. Early Diagnosis of Axial Spondyloarthritis Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria. Imaging in Axial Spondyloarthritis Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.
Axial & Psoriatic Disease Dr. Peter Nash at Eular 2024 in Vienna, Austria. Difficult to Treat Psoriatic Arthritis Dr. Peter Nash reports at Eular 2024 in Vienna, Austria. Predictors of Treatment Response in Psoriatic Arthritis Dr. Janet Pope reviews three abstracts presented at Eular 2024 in Vienna, Austria. Abstracts discussed: POS 0990 POS 0992 POS 0266 Prevention of Psoriatic Arthritis Dr. Peter Nash sharing his perspectives on preventing psoriasis from turning into PsA at Eular 2024 in Vienna, Austria. Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria. Digital Rheumatology Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria. Drug-resistant RA Does Blinatumomab BiTE? Dr. Yuz Yusof reports on abstract OP0193, presented at Eular 2024 in Vienna, Austria. Early Diagnosis of Axial Spondyloarthritis Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria. Imaging in Axial Spondyloarthritis Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.
Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria.
Jamie kicks this episode off by sharing her thoughts on the importance of estate planning for parents, not only financially but also the care and values that parents would like their children to have. She discusses her recent experience with The Parents Estate Planning Law Firm in Massachusetts, and highlights an upcoming free workshop on this topic as well as the option for listeners to book a call with the firm to learn more. Jamie introduces the guests for this episode, Dr. Cory Whelan and Dr. Kara LaCroix, co-founders of Seasons Behavioral Services, who provide valuable insights and resources for families supporting individuals with autism. Dr. Whelan and Dr. LaCroix chat with Emily, sharing their journey in founding their organization and explain the process and importance of early intervention and support for families navigating autism diagnoses.The conversation delves into the intricacies of Applied Behavior Analysis (ABA) services, highlighting its role in helping children and adults with developmental disabilities and autism. They discuss the importance of early diagnosis and intervention to improve outcomes and emphasize the significance of parental support and community resources to navigate the complexities of raising a child with autism. In this week's Q&A, Jamie addresses a parent's concern about their four-month-old waking up frequently at night, explaining the concept of the four-month sleep regression. Jamie also mentions Nurture's sleep consultation services for personalized support. Workshop with Jamie O'Day and Parents Estate Planning Book a call with Parents Estate Planning Law Firm This podcast is proudly brought to you by our fabulous sponsors: Feast & Fettle: Use code NAPSPOD for $30 off your first order kozēkozē: Use code NAPS for 20% off your purchase Kibou: Use code NAPS for 15% off your purchase of $89+
Today we're tackling the challenge of decoding ADHD in children. Emily Kircher-Morris chats with Drs. Yael Rothman and Katia Fredriksen about the cultural and socioeconomic factors that influence the diagnosis, the disparities in diagnosis rates among different racial and ethnic groups, and the impact of stigma. They also explore the benefits of early diagnosis and intervention, and of recognizing and leveraging the strengths often inherent in ADHD. They touch on a host of other subjects as well, on episode 223. Takeaways Cultural and socioeconomic factors influence the diagnosis and management of ADHD in children, leading to disparities in diagnosis rates among different racial and ethnic groups. Early diagnosis and intervention are beneficial for children with ADHD, as it helps with de-stigmatization, self-esteem, and self-advocacy. ADHD individuals have unique strengths, such as creative thinking, hyperfocus, and resilience, which can be leveraged for success. Having conversations with children about their diagnosis is important for their understanding and self-acceptance. Parents should take time to process information, ask questions, and prioritize their own mental health throughout the diagnosis and management process. To learn more about the Neurodiversity University courses for educators, click the link, and get in touch with us through the contact page if you have questions. Join the Neurodiversity Podcast Advocacy & Support Group on Facebook! Dr. Katia Fredriksen and Dr. Yael Rothman are pediatric neuropsychologists at a private practice, where they complete assessments with children and adolescents with a wide range of conditions that impact learning, behavior, and/or socioemotional functioning. They recently published the first book of their Different Thinkers series, designed to provide elementary-age children with a resource to understand their diagnosis, manage the associated difficulties, and appreciate the many strengths that come along with their profiles. Their first book, Different Thinkers: ADHD, focuses on the diagnosis of ADHD. Dr. Fredriksen trained at Princeton University and the University of Massachusetts Boston. She lives with her family in Arlington, Virginia. Dr. Rothman trained at the University of Michigan and Ferkauf Graduate School of Psychology. She lives with her family in Washington, D.C. BACKGROUND READING Website Instagram Facebook Twitter/X Different Thinkers: ADHD
In this episode, my guest is Dr. Karen Parker, Ph.D., professor of psychiatry and director of the Social Neurosciences Research Program at Stanford University School of Medicine. We discuss the biology of social connections and bonding in babies, children and adults. Dr. Parker explains our current understanding of autism and autism spectrum disorders: what they are, why the incidence of autism has increased so dramatically in recent years and both the current and emerging treatments for autism. We also discuss the condition formerly called “Asperger's.” This episode is highly relevant for anyone interested in child and human development, how social bonds and communication form, and those curious about autism and other spectrum conditions. For show notes, including referenced articles and additional resources, please visit hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://eightsleep.com/huberman LMNT: https://drinklmnt.com/huberman AeroPress: https://aeropress.com/huberman InsideTracker: https://insidetracker.com/huberman Momentous: https://livemomentous.com/huberman Timestamps (00:00:00) Dr. Karen Parker (00:01:30) Sponsors: Eight Sleep, LMNT & AeroPress (00:06:25) Autism, Frequency, Diagnosis (00:10:41) Early Interventions; Heritability & Autistic Traits (00:13:00) Autistic Spectrums; Studying Autism (00:21:29) Environment, Risk Factors & In Utero Development (00:29:55) Sponsor: AG1 (00:31:26) Oxytocin, Vasopressin, Social Behavior & Parent-Child Bonding (00:43:240 Oxytocin in Humans; Social Features of Autism, Intranasal Oxytocin (00:54:14) Sponsor: InsideTracker (00:55:16) Oxytocin & Autism; Benefit & Risks (01:06:30) Neuroplasticity & Autism; Early Intervention; Challenges of Early Diagnosis (01:14:30) MDMA & Autism (01:17:05) Vasopressin, Social Interaction; Voles & Parenthood (01:27:07) Human Social Connection, Oxytocin Levels & Autism (01:33:45) Primate Model of Social Impairment (01:42:47) Preclinical Animal Models, Mouse & Primates (01:47:11) Primates, Biomarkers & Social Connection; Vasopressin (01:52:20) Vasopressin Levels & Autism, Children & In Utero (02:03:06) Cerebral Spinal Fluid (CSF) & Vasopressin; Urination; Alternative Therapies (02:10:32) Intranasal Vasopressin, Children, Autism & Social Responsiveness (02:19:15) Vasopressin & Social Connection, Mechanism & Future Studies (02:26:35) Gut Microbiome & Vasopressin; Scientific Funding (02:34:52) Vasopressin Pathways, Social Behavior, Autism (02:43:00) Vaccine Theory & Autism; Immunology (02:54:06) Zero-Cost Support, Spotify & Apple Reviews, Sponsors, YouTube Feedback, Momentous, Social Media, Neural Network Newsletter Disclaimer
© 2020-2025 Ivy Podcast Discovery LLC
